News

Director of Discovery Dr. Erik Procko recently performed a presentation on Cyrus’ novel IgG-degrading IdeS enzyme development candidates at PepTalk Conference San Diego on January 16th. The article can be found via …

By Sam DeLuca, Ph.D. With Steven Lewis, Ph.D. and Lucas Nivon, Ph.D. In our previous article in March 2023, we discussed our experience benchmarking publicly available AI protein design tools and exploring their real …

Protein AI tools are useful for aggressive protein design, while physics based tools continue to be required for re-design of natural proteins for most cases By Steven Lewis, Dan Farrell, Brandon Frenz, …

OpenFold, a non-profit artificial intelligence (AI) research consortium whose goal is to develop free and open source software tools for biology and drug discovery, today announced the addition of four new industry members: …

Recent advances in the architecture and scale of AI are leading us from the era of narrowly focused AI (e.g. text auto-complete, immune epitope prediction in a protein sequence, antibody domain detection) …

Career Insights.

Join CyrusBio and provide solutionsfor 120+ biotech/pharma companies.